Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-03-16 Sale | 2026-03-17 4:10 pm | Oruka Therapeutics Inc. | ORKA | Klein Lawrence Otto Chief Executive Officer | 1,729 | $41.3 | $71,408 | 927,309 (Direct) | View |
| 2026-03-16 Sale | 2026-03-17 4:09 pm | Oruka Therapeutics Inc. | ORKA | Agarwal Arjun Senior Vice President, Finance | 395 | $41.3 | $16,313 | 18,863 (Direct) | View |
| 2026-03-16 Sale | 2026-03-17 4:08 pm | Oruka Therapeutics Inc. | ORKA | Sandler Laura Lee Chief Operating Officer | 600 | $41.3 | $24,780 | 236,984 (Direct) | View |
| 2026-03-16 Sale | 2026-03-17 4:06 pm | Oruka Therapeutics Inc. | ORKA | Goncalves Joana Chief Medical Officer | 7,641 | $40.91 | $312,560 | 433,932 (Direct) | View |
| 2026-03-16 Sale | 2026-03-17 4:04 pm | Oruka Therapeutics Inc. | ORKA | Quinlan Paul T General Counsel | 733 | $41.3 | $30,273 | 31,767 (Direct) | View |
| 2026-03-02 Sale | 2026-03-02 6:47 pm | Oruka Therapeutics Inc. | ORKA | Sandler Laura Lee Chief Operating Officer | 5,000 | $33.56 | $167,822 | 327,580 (Direct) | View |
| 2026-02-17 Sale | 2026-02-17 5:24 pm | Oruka Therapeutics Inc. | ORKA | Goncalves Joana Chief Medical Officer | 7,000 | $32.37 | $226,559 | 441,573 (Direct) | View |
| 2026-01-15 Sale | 2026-01-16 5:26 pm | Oruka Therapeutics Inc. | ORKA | Goncalves Joana Chief Medical Officer | 7,000 | $31.81 | $222,704 | 416,073 (Direct) | View |
| 2026-01-02 Sale | 2026-01-02 8:25 pm | Oruka Therapeutics Inc. | ORKA | Sandler Laura Lee Chief Operating Officer | 13,000 | $28.52 | $370,795 | 300,080 (Direct) | View |
| 2025-12-19 Sale | 2025-12-19 5:38 pm | Oruka Therapeutics Inc. | ORKA | Goncalves Joana Chief Medical Officer | 7,000 | $30.61 | $214,293 | 423,073 (Direct) | View |
| 2025-02-10 Purchase | 2025-02-27 6:42 pm | Oruka Therapeutics Inc. | ORKA | Venrock Healthcare Capital Partners III L.P. VHCP Co-Investment Holdings III LLC VHCP Management EG LLC Venrock Healthcare Capital Partners EG L.P. VHCP Management III LLC Koh Bong Y Shah Nimish P 10% Owner | 122,882 | $11.45 | $1,407,368 | 4,148,428 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-03-16 Exercise | 2026-03-17 4:06 pm | N/A 2034-05-06 | Oruka Therapeutics Inc. | ORKA | Goncalves Joana Chief Medical Officer | 7,000 | $0 | 433,932 (Direct) | View |
| 2026-03-16 Exercise | 2026-03-17 4:06 pm | N/A N/A | Oruka Therapeutics Inc. | ORKA | Goncalves Joana Chief Medical Officer | 3,500 | $6.84 | 433,932 (Direct) | View |
| 2026-03-16 Exercise | 2026-03-17 4:06 pm | N/A N/A | Oruka Therapeutics Inc. | ORKA | Goncalves Joana Chief Medical Officer | 3,500 | $7.8 | 433,932 (Direct) | View |
| 2026-03-02 Exercise | 2026-03-02 6:47 pm | N/A 2034-07-14 | Oruka Therapeutics Inc. | ORKA | Sandler Laura Lee Chief Operating Officer | 5,000 | $0 | 327,580 (Direct) | View |
| 2026-03-02 Exercise | 2026-03-02 6:47 pm | N/A N/A | Oruka Therapeutics Inc. | ORKA | Sandler Laura Lee Chief Operating Officer | 5,000 | $7.8 | 327,580 (Direct) | View |
| 2026-02-17 Exercise | 2026-02-17 5:24 pm | N/A 2034-05-06 | Oruka Therapeutics Inc. | ORKA | Goncalves Joana Chief Medical Officer | 7,000 | $0 | 441,573 (Direct) | View |
| 2026-02-17 Exercise | 2026-02-17 5:24 pm | N/A N/A | Oruka Therapeutics Inc. | ORKA | Goncalves Joana Chief Medical Officer | 3,500 | $6.84 | 441,573 (Direct) | View |
| 2026-02-17 Exercise | 2026-02-17 5:24 pm | N/A N/A | Oruka Therapeutics Inc. | ORKA | Goncalves Joana Chief Medical Officer | 3,500 | $7.8 | 441,573 (Direct) | View |
| 2026-01-23 Option Award | 2026-01-23 5:40 pm | N/A 2036-01-22 | Oruka Therapeutics Inc. | ORKA | Goncalves Joana Chief Medical Officer | 162,500 | $0 | 164,018 (Direct) | View |
| 2026-01-23 Option Award | 2026-01-23 5:40 pm | N/A 2036-01-22 | Oruka Therapeutics Inc. | ORKA | Sandler Laura Lee Chief Operating Officer | 162,500 | $0 | 367,584 (Direct) | View |
| 2026-01-23 Option Award | 2026-01-23 5:40 pm | N/A 2036-01-22 | Oruka Therapeutics Inc. | ORKA | Agarwal Arjun SVP, Finance | 87,500 | $0 | 89,258 (Direct) | View |
| 2026-01-23 Option Award | 2026-01-23 5:38 pm | N/A 2036-01-22 | Oruka Therapeutics Inc. | ORKA | Klein Lawrence Otto Chief Executive Officer | 383,400 | $0 | 1,235,738 (Direct) | View |
| 2026-01-23 Option Award | 2026-01-23 5:36 pm | N/A 2036-01-22 | Oruka Therapeutics Inc. | ORKA | Quinlan Paul T General Counsel | 162,500 | $0 | 162,500 (Direct) | View |
| 2026-01-23 Other | 2026-01-23 4:31 pm | N/A N/A | Oruka Therapeutics Inc. | ORKA | Dambkowski Carl Director | 116,483 | $0 | 232,966 (Direct) | View |
| 2026-01-15 Exercise | 2026-01-16 5:26 pm | N/A 2034-05-06 | Oruka Therapeutics Inc. | ORKA | Goncalves Joana Chief Medical Officer | 7,000 | $0 | 416,073 (Direct) | View |
| 2026-01-15 Exercise | 2026-01-16 5:26 pm | N/A N/A | Oruka Therapeutics Inc. | ORKA | Goncalves Joana Chief Medical Officer | 3,500 | $6.84 | 416,073 (Direct) | View |
| 2026-01-15 Exercise | 2026-01-16 5:26 pm | N/A N/A | Oruka Therapeutics Inc. | ORKA | Goncalves Joana Chief Medical Officer | 3,500 | $7.8 | 416,073 (Direct) | View |
| 2026-01-02 Exercise | 2026-01-02 8:25 pm | N/A 2034-07-14 | Oruka Therapeutics Inc. | ORKA | Sandler Laura Lee Chief Operating Officer | 5,000 | $0 | 300,080 (Direct) | View |
| 2026-01-02 Exercise | 2026-01-02 8:25 pm | N/A N/A | Oruka Therapeutics Inc. | ORKA | Sandler Laura Lee Chief Operating Officer | 5,000 | $7.8 | 300,080 (Direct) | View |
| 2025-12-19 Exercise | 2025-12-19 5:38 pm | N/A 2034-05-06 | Oruka Therapeutics Inc. | ORKA | Goncalves Joana Chief Medical Officer | 7,000 | $0 | 423,073 (Direct) | View |
| 2025-12-19 Exercise | 2025-12-19 5:38 pm | N/A N/A | Oruka Therapeutics Inc. | ORKA | Goncalves Joana Chief Medical Officer | 3,500 | $6.84 | 423,073 (Direct) | View |
| 2025-12-19 Exercise | 2025-12-19 5:38 pm | N/A N/A | Oruka Therapeutics Inc. | ORKA | Goncalves Joana Chief Medical Officer | 3,500 | $7.8 | 423,073 (Direct) | View |
| 2025-12-11 Option Award | 2025-12-11 4:41 pm | N/A 2035-12-10 | Oruka Therapeutics Inc. | ORKA | Martin Christopher Nathan Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2025-09-17 Option Award | 2025-09-19 5:33 pm | N/A N/A | Oruka Therapeutics Inc. | ORKA | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest III L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 333,340 | $15 | 3,705,262 (Indirect) | View |
| 2025-07-01 Option Award | 2025-07-01 9:26 pm | N/A 2035-06-30 | Oruka Therapeutics Inc. | ORKA | Sandler Laura Lee Chief Operating Officer | 25,000 | $0 | 25,000 (Direct) | View |
Ownership | 2025-07-01 9:21 pm | N/A N/A | Oruka Therapeutics Inc. | ORKA | Sandler Laura Lee Chief Operating Officer | 0 | $0 | 450,580 (Direct) | View |
| 2025-06-02 Option Award | 2025-06-03 4:30 pm | N/A 2035-06-01 | Oruka Therapeutics Inc. | ORKA | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest III L.P. Harwin Peter Evan Kiselak Tomas Director 10% Owner | 17,500 | $0 | 17,500 (Indirect) | View |
| 2025-06-02 Option Award | 2025-06-03 4:14 pm | N/A 2035-06-01 | Oruka Therapeutics Inc. | ORKA | Kulkarni Samarth Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2025-06-02 Option Award | 2025-06-03 4:13 pm | N/A 2035-06-01 | Oruka Therapeutics Inc. | ORKA | Dambkowski Carl Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2025-06-02 Option Award | 2025-06-03 4:13 pm | N/A 2035-06-01 | Oruka Therapeutics Inc. | ORKA | Turtle Cameron Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2025-06-02 Option Award | 2025-06-03 4:10 pm | N/A 2035-06-01 | Oruka Therapeutics Inc. | ORKA | BALL KRISTINE M Director | 17,500 | $0 | 17,500 (Direct) | View |
Ownership | 2025-02-27 6:42 pm | N/A N/A | Oruka Therapeutics Inc. | ORKA | Venrock Healthcare Capital Partners III L.P. VHCP Co-Investment Holdings III LLC VHCP Management III LLC Venrock Healthcare Capital Partners EG L.P. VHCP Management EG LLC Koh Bong Y Shah Nimish P 10% Owner | 0 | $0 | 4,550,089 (Indirect) | View |
| 2025-01-22 Option Award | 2025-01-24 4:44 pm | N/A 2035-01-21 | Oruka Therapeutics Inc. | ORKA | Agarwal Arjun SVP, Finance | 120,000 | $0 | 120,000 (Direct) | View |
| 2025-01-22 Option Award | 2025-01-24 4:43 pm | N/A 2035-01-21 | Oruka Therapeutics Inc. | ORKA | Goncalves Joana Chief Medical Officer | 162,500 | $0 | 162,500 (Direct) | View |
| 2025-01-22 Option Award | 2025-01-24 4:42 pm | N/A 2035-01-21 | Oruka Therapeutics Inc. | ORKA | Quinlan Paul T General Counsel | 162,500 | $0 | 162,500 (Direct) | View |
| 2025-01-22 Option Award | 2025-01-24 4:41 pm | N/A 2035-01-21 | Oruka Therapeutics Inc. | ORKA | Klein Lawrence Otto Chief Executive Officer | 230,000 | $0 | 230,000 (Direct) | View |
| 2024-11-19 Exercise | 2024-11-21 6:30 pm | N/A N/A | Oruka Therapeutics Inc. | ORKA | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 160,160 | $0 | 3,371,922 (Indirect) | View |
| 2024-09-11 Option Award | 2024-09-13 4:55 pm | N/A N/A | Oruka Therapeutics Inc. | ORKA | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 160 | $23,000 | 3,212,082 (Indirect) | View |
| 2024-09-11 Option Award | 2024-09-13 4:55 pm | N/A N/A | Oruka Therapeutics Inc. | ORKA | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 275,000 | $23 | 3,212,082 (Indirect) | View |
Ownership | 2024-09-06 5:07 pm | N/A N/A | Oruka Therapeutics Inc. | ORKA | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest III L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 0 | $0 | 19,662,752 (Indirect) | View |
Ownership | 2024-09-06 5:07 pm | N/A N/A | Oruka Therapeutics Inc. | ORKA | Turtle Cameron Director | 0 | $0 | 94,281 (Indirect) | View |
Ownership | 2024-09-06 5:06 pm | N/A 2034-03-22 | Oruka Therapeutics Inc. | ORKA | Kulkarni Samarth Director | 0 | $0 | 199,992 (Direct) | View |
Ownership | 2024-09-06 5:05 pm | N/A 2024-05-06 | Oruka Therapeutics Inc. | ORKA | Dambkowski Carl Director | 0 | $0 | 94,282 (Direct) | View |
Ownership | 2024-09-06 5:04 pm | N/A 2034-05-06 | Oruka Therapeutics Inc. | ORKA | BALL KRISTINE M Director | 0 | $0 | 94,282 (Direct) | View |
Ownership | 2024-09-06 5:03 pm | N/A 2034-05-06 | Oruka Therapeutics Inc. | ORKA | Quinlan Paul T General Counsel and Secretary | 0 | $0 | 328,559 (Direct) | View |